Download video

HDAC6 Inhibitors in Prostate Cancer: Enhancing Chemotherapy Sensitivity

37 views

Cell Biology & Drug Development

8 months ago

HDAC6 Inhibitors in Prostate Cancer: Enhancing Chemotherapy Sensitivity

HDAC6 Inhibitors in Prostate Cancer: Enhancing Chemotherapy Sensitivity

HDAC6 Inhibitors in Prostate Cancer: Enhancing Chemotherapy Sensitivity
3:37
HDAC6 Inhibitors in Prostate Cancer: Enhancing Chemotherapy Sensitivity
by Cell Biology \& Drug Development
The effect of HDAC6 inhibitors on neuronal complexity
2:10
The effect of HDAC6 inhibitors on neuronal complexity
by VJNeurology
Novel HDAC6 inhibitor, ricolinostat, for the treatment of multiple myeloma
4:11
Novel HDAC6 inhibitor, ricolinostat, for the treatment of multiple myeloma
by VJHemOnc – Video Journal of Hematology \& HemOnc
Secondary Biomarkers for Prostate Cancer Clinical Overview 2025With Dr. Pavlovich
13:52
Secondary Biomarkers for Prostate Cancer Clinical Overview 2025With Dr. Pavlovich
by Grand Rounds in Urology
Bladder Cancer Evidence
49:48
Bladder Cancer Evidence
by Rad Onc Talks
Artificial Intelligence in Benign Prostatic Hyperplasia
6:00
Artificial Intelligence in Benign Prostatic Hyperplasia
by Master the Urology
Imaging of Head\&Neck Squamous Cell Carcinoma
45:05
Imaging of Head\&Neck Squamous Cell Carcinoma
by The Neuroradiologist
New Concepts in Molecularly Targeted Radiation in Prostate Cancerwith Dr. Sartor
14:57
New Concepts in Molecularly Targeted Radiation in Prostate Cancerwith Dr. Sartor
by Grand Rounds in Urology
GC33317 HDAC6-IN-1 1815580-06-3
0:21
GC33317 HDAC6-IN-1 1815580-06-3
by glpbio Niki
PSA Greater Than 0.2 After 6-12 Months of Treatment for mHSPC Intensified by ARPI
9:10
PSA Greater Than 0.2 After 6-12 Months of Treatment for mHSPC Intensified by ARPI
by GU Oncology Now
Testicular Cancer - Seminoma Evidence
45:03
Testicular Cancer - Seminoma Evidence
by Rad Onc Talks
Latest Approaches and Clinical Trials in Metastatic Hormone-sensitive Prostate Cancer with Dr. Dorff
15:18
Latest Approaches and Clinical Trials in Metastatic Hormone-sensitive Prostate Cancer with Dr. Dorff
by Grand Rounds in Urology
Treatment Options for HER2 Positive Biliary Tract Cancers
18:30
Treatment Options for HER2 Positive Biliary Tract Cancers
by OncBrothers: Practice-Changing Cancer Discussions
Rocilinostat (ACY-1215) - Selective HDAC6 Inhibitor
0:37
Rocilinostat (ACY-1215) - Selective HDAC6 Inhibitor
by kelly zen
Histone deacetylase (HDAC) inhibitors
2:50
Histone deacetylase (HDAC) inhibitors
by Myeloma UK
Education Session HER2 IHC in Breast 24SEP2025
54:12
Education Session HER2 IHC in Breast 24SEP2025
by CADQAS CIC
Impact of CDK4\/6 inhibitors on HR-positive, HER2-negative advanced breast cancer
1:58
Impact of CDK4\/6 inhibitors on HR-positive, HER2-negative advanced breast cancer
by VJOncology
Permanent Prostate Brachytherapy as a Treatment for Prostate Cancer with Dr. Brian J. Davis, MD, PhD
31:44
Permanent Prostate Brachytherapy as a Treatment for Prostate Cancer with Dr. Brian J. Davis, MD, PhD
by Grand Rounds in Urology
Using HDAC Inhibitors to Improve Cancer Immunotherapy
44:25
Using HDAC Inhibitors to Improve Cancer Immunotherapy
by Labroots
Prognostic value of intrinsic subtypes in HR+\/HER2- breast cancer after CDK4\/6 inhibitors
3:07
Prognostic value of intrinsic subtypes in HR+\/HER2- breast cancer after CDK4\/6 inhibitors
by VJOncology
EMBARK: metastasis-free survival by prior treatment in hrBCR prostate cancer
0:55
EMBARK: metastasis-free survival by prior treatment in hrBCR prostate cancer
by VJOncology
Enhancing our understanding of HRR gene defects in prostate cancer
0:37
Enhancing our understanding of HRR gene defects in prostate cancer
by VJOncology
The role of CDK4\/6 inhibitors with ET in HR+\/HER2− breast cancer
1:26
The role of CDK4\/6 inhibitors with ET in HR+\/HER2− breast cancer
by VJOncology